Investigation on the use of fused deposition modeling for the production of IR dosage forms containing Timapiprant

The present work focused on evaluating the feasibility of fused deposition modeling (FDM) in the development of a dosage form containing Timapiprant (TMP), also known as CHF6532, which is a novel active molecule indicated in the potential treatment of eosinophilic asthma upon oral administration. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Uboldi, Marco, Chiappa, Arianna, Pertile, Marisa, Piazza, Alessandro, Tagliabue, Stefano, Foppoli, Anastasia, Palugan, Luca, Gazzaniga, Andrea, Zema, Lucia, Melocchi, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Special Issue on Latest trends in pharmaceutical printing
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823139/
https://www.ncbi.nlm.nih.gov/pubmed/36624741
http://dx.doi.org/10.1016/j.ijpx.2022.100152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823139/
https://www.ncbi.nlm.nih.gov/pubmed/36624741
http://dx.doi.org/10.1016/j.ijpx.2022.100152

Ejemplares similares